CCR10 and psoriasis: Among them, observational studies have shown that restoration of the CTACK/CCR10 immunoregulatory impairments caused by psoriasis suppresses skin T-cell hyperactivation, thereby reducing the inflammatory response associated with psoriasis (28, 29).